Zhang Shengwei, Jiang Yanliang, Cheng Qi, Zhong Yi, Qin Yali, Chen Mingzhou
State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, China.
Hubei University of Chinese Medicine, School of Laboratory Medicine, Wuhan, China.
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.01802-16. Print 2017 Feb 1.
Viral inclusion bodies (IBs), or replication factories, are unique structures generated by viral proteins together with some cellular proteins as a platform for efficient viral replication, but little is known about the mechanism underlying IB formation and fusion. Our previous study demonstrated that the interaction between the nucleoprotein (N) and phosphoprotein (P) of human parainfluenza virus type 3 (HPIV3), an enveloped virus with great medical impact, can form IBs. In this study, we found that small IBs can fuse with each other to form large IBs that enhance viral replication. Furthermore, we found that acetylated α-tubulin interacts with the N-P complex and colocalizes with IBs of HPIV3 but does not interact with the N-P complex of human respiratory syncytial virus or vesicular stomatitis virus and does not colocalize with IBs of human respiratory syncytial virus. Most importantly, enhancement of α-tubulin acetylation using the pharmacological inhibitor trichostatin A (TSA), RNA interference (RNAi) knockdown of the deacetylase enzymes histone deacetylase 6 (HDAC6) and sirtuin 2 (SIRT2), or expression of α-tubulin acetyltransferase 1 (α-TAT1) resulted in the fusion of small IBs into large IBs and effective viral replication. In contrast, suppression of acetylation of α-tubulin by overexpressing HDAC6 and SIRT2 profoundly inhibited the fusion of small IBs and viral replication. Our findings offer previously unidentified mechanistic insights into the regulation of viral IB fusion by acetylated α-tubulin, which is critical for viral replication.
Inclusion bodies (IBs) are unique structures generated by viral proteins and some cellular proteins as a platform for efficient viral replication. Human parainfluenza virus type 3 (HPIV3) is a nonsegmented single-stranded RNA virus that mainly causes lower respiratory tract disease in infants and young children. However, no vaccines or antiviral drugs for HPIV3 are available. Therefore, understanding virus-host interactions and developing new antiviral strategies are increasingly important. Acetylation on lysine (K) 40 of α-tubulin is an evolutionarily conserved modification and plays an important role in many cellular processes, but its role in viral IB dynamics has not been fully explored. To our knowledge, our findings are the first to show that acetylated α-tubulin enhances viral replication by regulating HPIV3 IB fusion.
病毒包涵体(IBs),即复制工厂,是由病毒蛋白与一些细胞蛋白共同形成的独特结构,作为高效病毒复制的平台,但关于IB形成和融合的潜在机制知之甚少。我们之前的研究表明,对医学影响重大的包膜病毒——人副流感病毒3型(HPIV3)的核蛋白(N)和磷蛋白(P)之间的相互作用可形成IBs。在本研究中,我们发现小的IBs可相互融合形成大的IBs,从而增强病毒复制。此外,我们发现乙酰化的α-微管蛋白与N-P复合物相互作用,并与HPIV3的IBs共定位,但不与人呼吸道合胞病毒或水疱性口炎病毒的N-P复合物相互作用,也不与人呼吸道合胞病毒的IBs共定位。最重要的是,使用药理抑制剂曲古抑菌素A(TSA)增强α-微管蛋白乙酰化、通过RNA干扰(RNAi)敲低去乙酰化酶组蛋白去乙酰化酶6(HDAC6)和沉默调节蛋白2(SIRT2),或表达α-微管蛋白乙酰转移酶1(α-TAT1),均导致小的IBs融合成大的IBs并实现有效的病毒复制。相反,通过过表达HDAC6和SIRT2抑制α-微管蛋白的乙酰化,可显著抑制小的IBs融合及病毒复制。我们的发现为乙酰化α-微管蛋白对病毒IB融合的调控提供了前所未有的机制见解,这对病毒复制至关重要。
包涵体(IBs)是由病毒蛋白和一些细胞蛋白形成的独特结构,作为高效病毒复制的平台。人副流感病毒3型(HPIV3)是一种不分节段的单链RNA病毒,主要导致婴幼儿下呼吸道疾病。然而,目前尚无针对HPIV3的疫苗或抗病毒药物。因此,了解病毒与宿主的相互作用并开发新抗病毒策略变得越发重要。α-微管蛋白赖氨酸(K)40位的乙酰化是一种进化上保守的修饰,在许多细胞过程中发挥重要作用,但其在病毒IB动态变化中的作用尚未得到充分探索。据我们所知,我们的发现首次表明乙酰化α-微管蛋白通过调节HPIV3的IB融合来增强病毒复制。